Google
SPRO — SPERO THERAPEUTICS INC (Healthcare >> Biotechnology)
SPRO FAQ
What is SPRO's P/E ratio?
SPERO THERAPEUTICS INC (SPRO) currently trades at a P/E ratio of 5.18.
What is SPRO's ROE?
SPERO THERAPEUTICS INC reports a Return on Equity (ROE) of 28.78%.
What is SPRO's dividend yield?
SPERO THERAPEUTICS INC offers a dividend yield of 0.00%.
What is SPRO's Deepscope Quality Score?
Deepscope rates SPRO's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SPRO?
Deepscope's AI Timing Score for SPRO is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SPRO belong to?
SPERO THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.82
Price
-0.16
(-5.37%)
Day Change
|
|
|---|
SPRO Chất lượng tổng thể của cố phiếu Khá ( Chất lượng = 62) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
55% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
147
|
| Magic Formula Rank by ROE |
147
|
| Magic Formula Rank by ROIC |
67
GOOD
|
| Price | 2.82 |
| PBV / Sector |
3.08 / 4.63
|
| Earning Per Share | 0.26 |
| PE / Sector |
5.18 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.02 / 0.53
|
| Average 1M Daily Value |
2.23 M
GREAT
|
| Average 1W Daily Value |
2.17 M
GREAT
|
| Yếu tố Kỹ thuật |
|
71% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
60% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:09:21 |
| Symbol | SPRO |
| Name | SPERO THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 57.90 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 163.28 / 8,857.28 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 675 Massachusetts Avenue, Cambridge, MA, United States, 02139
Phone: 857 242 1600
Website: https://sperotherapeutics.com
Sector: Healthcare >> Biotechnology
Description: Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which has completed second Phase 3 trial. It has license agreement with Meiji Seika Pharma Co., Ltd. to develop, manufacture, and commercialize tebipenem pivoxil and tebipenem HBr; and Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries. Spero Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
